The RNA-dependent RNA polymerase of influenza virus transcribes messenger RNA through a unique cap-scavenging mechanism. The polymerase binds to the cap structure at the 5′ ends of host mRNAs, which are then cleaved and used as primers for viral mRNA synthesis. In an effort to discover antiviral compounds against this target, an in-vitro transcription assay was utilized to screen a proprietary chemical collection. Results of this screening effort identified an N-hydroxamic acid structure as an inhibitor of the capped RNA-dependent transcriptase activity. Subsequent sub-structure searching and screening based upon this pharmacophore identified two related N-hydroxyimide compounds as specific inhibitors. These compounds were found to inhibit the cap-scavenging mechanism through inhibition of the endonuclease function of the polymerase.
BanerjeeA.K. (1987) The transcription complex of vesicular stomatitis virus. Cell48: 363–364.
2.
BanerjeeA.K.MoyerS.A., and RhodesD.P. (1974) Studies on the in vitro adenylation of RNA by vesicular stomatitis virus. Virology61: 547–558.
3.
BarbosaE., and MossB. (1978) mRNA(nucieoside-2′)-methyltransferase from vaccinia virus. Purification and physical properties. J Biol Chem253: 7692–7697.
4.
BarrettT., and InglisS.C. (1985) Growth, purification and titration of influenza viruses. In Virology: A Practical Approach. MahyB.W.J. (ed.). Oxford: IRL Press, pp. 119–150.
5.
BettsR.F. (1991) Resistance to rimantadine and amantadine. Current Opinion in In fections Diseases4: 804–808.
6.
BettsR.F. (1992) Potential agents in the treatment of influenza. Current Opinion in In fections Diseases5: 811–815.
7.
BishopD.H.L.ObijeskiJ.F., and SimpsonR.W. (1971) Transcription of the influenza ribonucleic acid genome by a virion polymerase. I. Optimal condition for in vitro activity of the ribonucleic acid-dependent ribonucleic acid polymerase. J Virol8: 66–71.
8.
BlokV.CianciC.TibbiesK.W.in GlisS.C.KrystalM., and DigardP. (1996) Inhibition of the Influenza virus RNA-dependent RNA polymerase by antisera directed against the PB2 subunit. J Gen Virol77: 1025–1033.
9.
BraamJ.UlmanenI., and KrugR.M. (1983) Molecular model of a eukaryotic transcription complex: functions and movements of influenza P proteins during capped RNA-primed transcription. Ce//34: 609–618.
10.
ChungT.D.Y.CianciC.HagenM.TerryB.T.MatthewsJ.T.KrystalM., and ColonnoR.J. (1994) Biochemical studies on capped RNA primers identify a class of oligonucleotide inhibitors of the influenza virus RNA polymerase. Proc Natl Acad Sci USA91: 2372–2376.
11.
CianciC.TileyL., and KrystalM. (1995) Differential activation of the influenza virus polymerase via template RNA binding. J Virol69: 3995–3999.
12.
CouchR.B. (1993) Advances in influenza virus vaccine research. Ann NY Acad of Sci685: 803–812.
13.
DrummondJ.JohnsonG.NickellD.G.OrtwineD.F.BrunsR.F., and WelbaumB. (1989) Evaluation and synthesis of amino-hydroxy isooxazoles and pyrazoles as potential glycine agonists. J Med Chem32: 2116–2128.
14.
GormanO.T.DonisR.O.KawaokaY., and WebsterR.G. (1990) Evolution of influenza A virus PB2 genes: implications for evolution of the ribonucleoprotein complex and origin of human influenza A virus. J Virol64: 4893–4902.
15.
HagenM.ChungT.D.Y.ButcherJ.A., and KrystalM. (1994) Recombinant influenza virus polymerase: requirement of both 5′ and 3′ viral ends for endonuclease activity. J Virol68: 1509–1515.
16.
HastingsJ.C.SelnickH.WolanskiB., and TomassiniJ.E. (1996) Anti-influenza virus activities of 4-substituted 2,4-dioxobutanoic acid inhibitors. Antimicrob Agents Chemother40: 1304–1307.
17.
HayA.J. (1992) The action of adamantanamines against influenza A viruses: inhibition of the M2 ion channel protein. Seminars in Virology3: 21–30.
18.
HaydenF.G., and CouchR.B. (1992) Clinical and epidemiological-importance of influenza A viruses resistant to amantadine and rimandatine. Medical Virol2: 89–96.
19.
HaydenF.G., and HayA.J. (1992) Emergence and transmission of influenza A viruses resistant to amantadine and rimantadine. Current Topics in Microbiol and Immunol176: 119–130.
20.
HaydenF.G.SperberS.J.BelsheR.B.CloverR.D.HayA.J., and PykeS. (1991) Recovery of drug-resistant influenza A virus during therapeutic use of rimantadine. Antimicrob Agents Chemother35: 1741–1747.
21.
HensensO.D.GoetzM.A.LieschJ.M.ZinkD.L.RaghoobarS.L.HelmsG.L., and SinghS.B. (1995) Isolation and structure of flutimide, a novel endonuclease inhibitor of influenza virus. Tet Lett36: 2005–2008.
22.
IshihamaA., and NagataK. (1988) Viral RNA polymerases. CRC Critical Reviews in Biochem23: 27–76.
23.
KawakamiK.MizumotoK.IshihamaA.ShinozakiYamguchiK., and Kin-IchiroM. (1985) Activation of influenza virus-associated RNA polymerase by cap-1 structure (m7GpppNm). J Biochem97: 655–661.
24.
Koper-ZwarthoffE.C.BrederodeFT.VeenemanG.van BoomJ.H., and BolJ.F. (1980) Sequences at the 5′ termini of the alfalfa mosaic virus RNAs and the intercistronic junction in RNA 3. Nucl Acids Res8: 5635–5647.
25.
KrugR.M. (1981) Priming of influenza viral RNA transcription by capped heterologous RNAs. Current Topics Microbiol Immunol93: 125–150.
26.
KrugR.M.BroniB.A.LaFiandraA.J.MorganM.A., and ShatkinA.J. (1980) Priming and inhibitory activities of RNA's for the influenza viral transcriptase do not require base pairing with the virion template RNA. Proc Natl Acad Sci USA77: 5874–5878.
27.
KrugR.M.Alonso-CaplenF.V.JulkunenI., and KatzeM.G. (1989) Expression and replication of the influenza virus genome. In The Influenza Viruses. KrugR.M. (ed.). New York: Plenum Press, pp. 89–152.
28.
LambR.A., and ChoppinP.W. (1983) The gene structure and replication of influenza virus. Ann Rev Biochem52: 467–506.
29.
MartellA.E., and SmithR.M. (1982) In Critical Stability Constants. New York: Plenum Press. 6: 378–379.
30.
PlotchS.J.BouloyM.UlmanenI., and KrugR.M. (1981) A unique cap (m7GpppXm)-dependent influenza virion endonuclease cleaves capped RNA's to generate the primers that initiate viral RNA transcription. Cell23: 847–858.
31.
RaymondK.N.ChungT.D.Y.PecararoV.L., and CarranoC.J. (1982) Iron removal from transferrin by siderophores and analogs, and determination of the number of bound tyrosines in metal transferrin complexes. In The Biochemistry and Physiology of Iron. SaltmanP., and HegenauerJ. (eds). New York: Elsevier Press Biomedical, pp. 649–662.
32.
RochavanskyO.M. (1976) RNA synthesized by ribonucleoprotein polymerase complexes isolated from influenza virus. Virology73: 327–338.
33.
RomineJ.L.MartinS.W.MeanwellN.A., and EppersonJ.R. (1994) Synthesis of 3-hydroxypyridine-2,4-diones. Addition of anilines to benzyloxy isocyanate to give N-hydroxy ureas. Synthesis8: 846–850.
34.
ScholtissekC. (1978) The genome of the influenza virus. Current Topics Microbiol Immunol80: 139–169.
35.
ShiL.SummersD.F.PengQ., and GalarzaJ.M. (1995) Influenza A virus RNA polymerase subunit PB2 is the endonuclease which cleaves host cell mRNA and functions only as the trimeric enzyme. Virology208: 38–47.
36.
SinghS.B. (1995) Total synthesis of flutimide, a novel endonuclease inhibitor of influenza virus. Tet Lett36: 2009–2012.
37.
StoofJ.C.BooijJ., and DrukarchB. (1992) Amantadine as N-methyl-aspartic acid receptor antagonist: new possibilities for therapeutic applications?Clin Neurol and Neurosurgery (Suppl) 94: S4–S6.
38.
TomassiniJ.SelnickH.DaviesM.E.ArmstrongM.E.BaldwinJ.BourgeoisM.HastingsJ.HazudaD.LewisJ.McClementsW.PonticelloG.RadzilowskiE.SmithG.TebbenA., and WolfeA. (1994) Inhibition of cap (m7GpppXm)-dependent endonuclease of influenza virus by 4-substituted 2,4-dioxobutanoic acid compounds. Antimicrob Agents Chemother38: 2827–2837.
39.
TomassiniJ.E.DaviesM.E.HastingsJ.C.LinghamR.MojenaM.RaghoobarS.L.SinghS.B.TkaczJ.S., and GoetzM.A. (1996) A novel antiviral agent which inhibits the endonuclease of influenza viruses. Antimicrob Agents Chemother40: 1189–1193.
40.
UlmanenI.BroniB.A., and KrugR.M. (1981) Role of two of the influenza virus core P proteins in recognizing Cap-1 structures (m7GpppNm) on RNAs and in initiating viral RNA transcription. Proc Natl Acad Sci USA78: 7355–7359.
41.
WebsterR.G., and BeanW.J. (1978) Genetics of influenza virus. Ann Rev Genetics12: 415–431.
42.
YamashitaM.KrystalM., and PaleseP. (1989) Comparison of the three large polymerase proteins of influenza A, B, and C viruses. Virology171: 458–466.
